The immunomodulatory-drug, lenalidomide, sustains and enhances interferon-α production by human plasmacytoid dendritic cells

Kayoko Kibata1 Kansai Medical University, First Department of Internal Medicine, Osaka, Japan

Tomoki Ito1 Kansai Medical University, First Department of Internal Medicine, Osaka, JapanCorrespondence[email protected]

https://orcid.org/0000-0001-5419-9156

Muneo Inaba1 Kansai Medical University, First Department of Internal Medicine, Osaka, Japan

Akihiro Tanaka1 Kansai Medical University, First Department of Internal Medicine, Osaka, Japan

Ryoichi Iwata2 Kansai Medical University, Department of Neurosurgery, Osaka, Japan

Noriko Inagaki-Katashiba1 Kansai Medical University, First Department of Internal Medicine, Osaka, Japan

Vien Phan1 Kansai Medical University, First Department of Internal Medicine, Osaka, Japan

Atsushi Satake1 Kansai Medical University, First Department of Internal Medicine, Osaka, Japan

Shosaku Nomura1 Kansai Medical University, First Department of Internal Medicine, Osaka, Japan

show all

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (7)

Alexia Barbarossa, Domenico Iacopetta, Maria Stefania Sinicropi, Carlo Franchini & Alessia Carocci. (2022) Recent Advances in the Development of Thalidomide-Related Compounds as Anticancer Drugs. Current Medicinal Chemistry 29:1, pages 19-40.
Crossref

Abu Tayab Moin, Mohammad Al-baruni Chowdhury, Sumaiya Hafiz Riana, Md. Asad Ullah, Yusha Araf, Bishajit Sarkar & Abdullah Mohammad Shohael. (2021) An Updated Overview of Herpes Simplex Virus-1 Infection: Insights from Origin to Mitigation Measures. Electronic Journal of General Medicine 18:4, pages em299.
Crossref

Kanchan Yadav, Rahul Shivahare, Salique Hassan Shaham, Prince Joshi, Anamika Sharma & Renu Tripathi. (2021) Repurposing of existing therapeutics to combat drug-resistant malaria. Biomedicine & Pharmacotherapy 136, pages 111275.
Crossref

Saeko Kuwahara‐Ota, Yuji Shimura, Christian Steinebach, Reiko Isa, Junko Yamaguchi, Daichi Nishiyama, Yuto Fujibayashi, Tomoko Takimoto‐Shimomura, Yoshimi Mizuno, Yayoi Matsumura‐Kimoto, Taku Tsukamoto, Yoshiaki Chinen, Tsutomu Kobayashi, Shigeo Horiike, Masafumi Taniwaki, Michael Gütschow & Junya Kuroda. (2020) Lenalidomide and pomalidomide potently interfere with induction of myeloid‐derived suppressor cells in multiple myeloma. British Journal of Haematology 191:5, pages 784-795.
Crossref

Vien Phan, Tomoki Ito, Muneo Inaba, Yoshiko Azuma, Kayoko Kibata, Noriko Inagaki-Katashiba, Akihiro Tanaka, Atsushi Satake & Shosaku Nomura. (2020) Immunomodulatory drugs suppress Th1-inducing ability of dendritic cells but enhance Th2-mediated allergic responses. Blood Advances 4:15, pages 3572-3585.
Crossref

Nidhi Gupta, Aparna Sharma & Alpana Sharma. (2020) Emerging biomarkers in Multiple Myeloma: A review. Clinica Chimica Acta 503, pages 45-53.
Crossref

Yutaka Tsukune, Makoto Sasaki & Norio Komatsu. (2019) Reactivation of Hepatitis B Virus in Patients with Multiple Myeloma. Cancers 11:11, pages 1819.
Crossref

The immunomodulatory-drug, lenalidomide, sustains and enhances interferon-α production by human plasmacytoid dendritic cells

Articles from other publishers (7)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The immunomodulatory-drug, lenalidomide, sustains and enhances interferon-α production by human plasmacytoid dendritic cells

Citations (7)

Articles from other publishers (7)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date